Introduction
The genomes of all known lentiviruses encode, in addition to the essential Gag, Pol and Env proteins, several so-called accessory proteins which regulate the complex viral life cycle and play a critical role in viral pathogenicity. One of these proteins, viral protein X (Vpx), is encoded by an open reading frame (ORF) located in the central part of the viral genome (Chakrabarti et al., 1987; Franchini et al., 1987; and is only found in human immunodeficiency virus type 2 (HIV-2) and the simian immunodeficiency viruses (SIVs) SIV ..... and SIVma e (Hirsch & Johnson, 1994) . Vpx is a protein of M r 14K (SIVs) or 16K (HIV-2) which is incorporated into viral particles in molar amounts comparable to those of the major Gag proteins (Henderson et al., 1988b; Yu et al., 1988; Franchini et al., 1988) . Native Vpx is neither glycosylated, nor phosphorylated (Franchini et al., 1988) , nor t Present address: Laboratory of Molecular Virology and Carcinogenesis, ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201, U.S.A. myristylated (Henderson et al., 1988b ) and apparently does not undergo extensive post-translational modifications (Yu et al., 1988) . Among the notable features of the amino acid sequence of Vpx are a proline-rich region at the carboxy terminus (Franchini et al., 1988) and a cysteine/histidine motif similar to the zinc-binding domains of retroviral nucleocapsid proteins (Henderson et al., 1988b; South et al., 1990) . With respect to the latter feature, purified Vpx has been shown to bind to single-stranded nucleic acids in vitro (Henderson et al., 1988b) . Analysis of protein sequence similarities has suggested that the vpx ORF arose by duplication of the viral protein R gene (vpr) (Tristem et al., 1990 (Tristem et al., , 1992 . Vpr is another virion-associated protein (Cohen et al., 1990; Yu et al., 1990) which is uniformly present in the HIV and SIV family (Hirsch & Johnson, 1994) . Both Vpx and Vpr are believed to act at an early stage of the viral life cycle (Cohen et al., 1990; Kappes et al., 1991) . Both proteins, although incorporated into virions, are dispensable for the assembly process (Desrosiers, 1992; Kappes et al., 1991) . Vpx from HIV-2 and SIV is required for efficient viral replication in primary lymphocyte and monocyte cultures but not in T lymphoid and monocytic cell lines (Guyader et 
Methods

Proviral clones of SIVm~ ~ and virus-producing cells.
The wild-type (wt) SIV ..... and a SIVm~ 0 vpx-deficient mutant (SIVm~ovpx-3) were generated from a parental proviral clone of SIVm~251 (pBK28; kindly provided by J. Mullins). Briefly, SIVma0Vpx-3 was constructed by mutating the ATG translation initiation codon of Vpx to ACG and deleting 163 bases within the vpx open reading frame from position 5961 to 6123 of the viral genome (coordinates from EMBL sequence databank: accession number M19499). wt SIVm~ o and SIVm~vpx-3 genomes were transfected by the DEAE-dextran procedure and were propagated on the T lymphoid cell line HUT-78 maintained in RPMI 1640 medium supplemented with 2mM-L-glutamine, 100lag/ml gentamicin and 10% fetal calf serum (FCS). Two days before harvesting infected-cell cultures or viral supernatants, uninfected HUT-78 cells were added to increase the yields of infectious material. Viral particles were routinely prepared from co-cultures of virus-producing cells with uninfected HUT-78 cells. The intensity of viral replication was measured by the reverse transcriptase assay using the micromethod described by T. O. Jonassen (Skatron application note, 1986).
Vaccinia virus constructs producing recombinant Vpx and virus-like particles of SIV~,~. Individual plasmids containing the sequences encoding Vpx, pl& "g and Pr56 g"g were derived by inserting SIV ...... DNA fragments from positions 5786 to 6222, 1035 to 1448 and 1037 to 2562, respectively (coordinates from EMBL sequence databank: accession number M19499) into the plasmid vector pTGI86 (Kieny et al., 1984) . These plasmids were used to isolate the vaccinia virus recombinants VV-vpx (VV.TG .4162), VV-pl6 g~g (VV.TG .4134) and VV-Pr56 g~q (VV.TG. 5118), encoding respectively Vpx, the myristylated matrix protein p 16 ~g and the entire Pr56 o~g polyprotein precursor from SIVm~¢, according to previously described procedures (Kieny et al., 1984) . Monolayers of BHK-21 cells grown in MEM supplemented with 2 mM-L-glutamine, 100 lag/ml gentamicin and 10% FCS were uniformly infected by VV-vpx and one of the other VV recombinants listed above (total m.o.i. 2 TC1Ds0/cell) for 2 h, washed with PBS and cultivated for 40 h at 37 °C.
Radiolabelling and radioimmunoprecipitation analysis (RIPA).
HUT-78 cells infected with wt SIV~a c were metabolically radiolabelled with [35S]methionine (1000 Ci/mmol) and [3~S]cysteine (600 Ci/mmol) at 100 laCi/ml (Amersham) in RPMI 1640 medium (Gibco) lacking methionine and cysteine and supplemented with 10% dialysed FCS (Gibco). Cells growing in suspension at 106 cells/ml were pelleted and resuspended at a 5-to 10-fold higher concentration and then radiolabelled for 12 h. The viral particles were concentrated from cellfree medium by centrifugation through a 20 % (w/v) sucrose cushion in TEN buffer (10 mM-Tris-HCl pH 7-5, 1 mM-EDTA, 150 mM-NaC1) at 70000 g for 4 h at 4 °C. The virion pellet was disrupted in cold RIPA buffer (50 mM-Tris HCI pH 7.5, 150 mu-NaC1, 1% NP40, 0-5% sodium deoxycholate, 0.1% SDS, supplemented with 1 mM-PMSF and 1 lag/ml aprotinin), kept on ice for 30 min and the particulate fraction was pelleted by ultracentrifugation at 436000g (OPTIMA TL; Beckman) for 7 min at 4 °C. The transparent pellet was washed, dissolved in TE buffer (10 mM-Tris HCI pH 7.5, 1 mM-EDTA) and both the pellet and supernatant fractions were immunoprecipitated (Maniatis et al., 1989 ) with a simian SIVm~o-positive serum selected for its ability to react with all SIV structural proteins. Immunoprecipitated materials were analysed on a 15 % SDS~olyacrylamide gel which was processed for fluorography.
Packaging of recombinant Vpx into virus-like particles was assayed after metabolic labelling with [~S]methionine and [35S]cysteine. BHK-21 cells were infected or co-infected by the recombinant vaccinia viruses as described above and metabolicaIly labelled for the duration of the infection (40 h at 37 °C). Radiolabelled particulate material was pelleted from cell-free medium by centrifugation at 120000 g for 4 h at 4°C through 1 ml of 25% (w/v) sucrose onto a 1 ml 45% (w/v) sucrose cushion in TEN. The interlayer fraction containing the pseudovirions was diluted in TEN (1:2) and centrifuged at 250000 g for 2h at 4°C. The pellet was lysed in ice cold RIPA buffer, immunoprecipitated with simian SIVmac-positive serum and analysed by 15% SDS PAGE.
Preparation of rabbit anti-Vpx antibodies.
To generate a rabbit serum directed against Vpx, !50 lag of purified, Escherichia coli-produced Vpx, in complete Freund's adjuvant, was injected subcutaneously for the first immunization. Booster immunizations were given on days 22 and 50 with 100 lag of the same protein in incomplete Freund's adjuvant and serum was collected 60 days after immunization. The specificity of the anti-Vpx antibodies was demonstrated by radioimmunoprecipitation with [aSS]methionine-and [35S]cysteine-radiolabelled viral proteins.
Immunoelectron microscopy. Infected cells were processed for immunoelectron microscopy essentially as described previously (Whitehouse et al., 1984; Spehner et al., 1991) . Briefly, ultrathin sections of samples embedded in Lowicryl K4M were collected on Formvar carbon-coated nickel grids. The grids were then incubated overnight with rabbit or simian antibodies raised against Vpx or SIVma ~ proteins respectively (dilution 1/1000). The grids were then washed with PBS and incubated with a second antibody coupled to colloidal gold particles and directed against the antibodies of the first species. Finally the grids were washed successively with PBS, postfixed with 2.5% glutaraldehyde in PBS, washed with water and stained with 1.8% uranyl acetate containing 0-2% methylcellulose. Samples were then examined with a Philips EM 410 transmission electron microscope.
For the preparation of viral capsids of SIVm~ c and their immunogoldlabelling the method described by Chrystie & Almeida (1989) was adapted. The virus-containing cell-free supernatants from SIVm~ oinfected HUT-78 cells were filtered (0.22 tam), layered onto a 20% (w/v) sucrose cushion in PBS and centrifuged at 70000g for 4 h at 4 °C. The viral pellets were immediately resuspended and treated with 0.1% NP40 and 0.1% glutaraldehyde in PBS for 30 min at 37 °C. This material was directly loaded onto glow discharged grids, incubated with rabbit anti-Vpx serum (dilution 1/1000), washed with PBS, then incubated with colloidal gold-coupled goat antibodies directed against rabbit immunoglobulins, washed with PBS and negatively stained with 2% uranyl acetate in water and observed by transmission electron microscopy (TEM).
Results
Localization of Vpx
As a first means to investigate the localization of Vpx in SIV ..... -infected cells and in virions we transfected HUT-78 cells with a wt SIVm~ c or vpx-deficient proviral clone and maintained these cells by serial passage. The virusproducing cells were fixed and embedded in Lowicryl K4M, a resin known to preserve antigenicity of HIV-1 structural proteins and allow immunolabelling (Grigoriev et at., 1989) . Ultrathin sections of infected cells were then incubated with rabbit anti-Vpx serum followed by goat anti-rabbit serum coupled to colloidal gold particles and examined by TEM. Little immunogold labelling was apparent in cells infected with the SIV .... (Fig. 1 c) . In contrast, gold particles, indicating the presence of Vpx, were found in the cytoplasm of cells infected with SIV .... wt and were particularly concentrated over virions that were in the process of budding or that had already been released from infected cells ( Fig. 1 a and b) . Up to 65 % of the viral particles produced after infection with wt SIV ..... were labelled with two or more gold particles. In instances where the core structures appeared welldefined, gold particles surrounded them (open arrows). Chrystie & Almeida (1989) described the recovery of antigenically reactive cores (also referred to as capsids) of HIV-2 virions using a suitably balanced mixture of detergent (NP40) and chemical cross-linker (glutaraldehyde). We have also employed this simple method for the preparation of viral cores of SIV .... . Electron microscopic examination of negatively stained preparations revealed the characteristic conical cores of SIV as well as the presence of viral particles and cores displaying various degrees of degradation (not shown). In agreement with Grief et al. (1989) , we did not notice any welldefined regular structure within the core shells. Occasionally, a unique isometric virion scaffold (Marx et al., 1988) , presumably composed of the matrix protein p 16 gag (MA) (Henderson et al., 1988a) , and containing a coneshaped core but devoid of the lipid membrane bilayer, was found in the preparations (Fig. 2, inset) . To determine the localization of Vpx, viral cores were pelleted, deposited on electron microscope grids, reacted with rabbit anti-Vpx antibodies then labelled with goat anti-rabbit I g G antibodies coupled to 5 n m gold particles, negatively stained with uranyl acetate and observed by electron microscopy. G o l d particles (arrows) were p r e d o m i n a n t l y visible on the a m o r p h o u s material that was attached to viral capsids ( (Fig. 3) . The particulate fraction contained two proteins, p28 gag (CA) and p8 g"g (NC), the latter is k n o w n to be closely associated with genomic R N A , but was devoid of significant a m o u n t s o f Vpx. In contrast, all structural viral proteins were present in the supernatant fraction, including Vpx. These results are consistent with the view that Vpx is not tightly associated with the viral r i b o n u c l e o p r o t e i n but rather that it lies at its periphery.
vpx-deficient mutant
Packaging of Vpx
To ascertain the viral proteins required for packaging o f Vpx, BHK-21 cells were co-infected with a vaccinia virus r e c o m b i n a n t encoding Vpx (VV-vpx and a VV recomb i n a n t encoding either the matrix protein p16 g~g (VVp16 g"g) or the Pr56 ~g precursor (VV-Pr56gag). (Fig. 4, lane 3) . Upon co-infection of cells with VV-p 16 g~g and VV-vpx there was no significant association of Vpx with the particulate material (Fig. 4, lane 4) . Particulate material produced from BHK-21 cells infected with VVPr56 g~g predominantly contained the Pr56 gag precursor, which is known to assemble into SIV-like particles (Fig.  4, lane 5) . Coinfection of cells with VV-vpx and VVPr56 gag resulted in the extracellular release of particulate material containing Vpx (Fig. 4, lane 6) . These results indicated that expression of the Pr56 gag polyprotein precursor was sufficient to bring about incorporation of Vpx into the particulate material.
Immunoelectron microscopy of BHK-21 cells infected with vaccinia virus recombinants was undertaken to confirm the identity of virus-like particles and the encapsidation of Vpx. In infections with VV-pl& ag and VV-Pr56 g~, virus-like particles were found in the process of budding at the plasma membrane or already released from the cells (Fig. 5) . VV-vpx did not induce the production of virus-like particles. Particles produced upon infection with VV-pl6 gao appeared as spherical membranes enclosing material of medium electron density (Fig. 5 a and b) . After coinfection with VV-vpx these particles could not be immunolabelled with antiVpx antibodies (Fig. 5b) although Vpx present in the cytoplasm of co-infected cells could be labelled (5c). Virus-like particles produced in cells infected with VVPr56 g"g alone (Fig. 5d) or VV-Pr56 g~g and VV-vpx (Fig.  5e ) were more electron dense than VV-pl6 g~g particles and in the latter instance were heavily labelled with antiVpx antibodies.
Discussion
Although Vpx has been known to be a virion-associatcd protein of HIV-2 and SIVs for several years, its precise localization within viral particles and the pathway for its assembly have not been extensively investigated. To address such questions, we have analysed, by immunoprecipitation and immunoelectron microscopy, infected cells and virus produced after infection with SIV .... or vaccinia virus recombinants encoding SIV .... proteins. Our experiments demonstrated that Vpx is associated with budding virions at the surface of infected cells and with mature virions released from the cell surface. The budding process is concomitant with or followed by the structural organization of virions during which the cores acquire their characteristic features and the cleavage of the Gag polyprotein occurs. It is likely that during this process Vpx reaches its particular position within virions. By treating virus particles with detergent and a crosslinking agent, intact virus cores as well as partially degraded cores could be isolated for immunoelectron microscopy. When such particles were subjected to immunogold labelling specific for Vpx, only the amorphous material attached to the cores bound the gold label, suggesting that Vpx is a protein component that surrounds virus cores. In agreement with Chrystie & Almeida (1989) and in contrast to Yu et al. (1993) we found that cores lost their characteristic structure when prepared in the absence of glutaraldehyde and furthermore that the use of this cross-linking agent was incompatible with detection of native viral proteins by SDS-PAGE (results not shown). Nevertheless, in another experimental approach, we were able to show that Vpx was not associated with the particulate material prepared by detergent lysis of viral particles in the absence of chemical cross-linkers. The proteins associated with the particulate material consisted primarily of the major core protein p28 gag (CA) and the RNAbinding protein p8 gag (NC). These results argue in favour of the localization of Vpx within the space that separates the virus core and the viral envelope and provide additional evidence for a similar conclusion recently reached by Yu et al. (1993) . It is noteworthy, however, that the presence of Vpx within virions could not be correlated with any structural feature apparent under the electron microscope.
Experiments presented here and others reported elsewhere (Yu et al., 1993; Kappes et al., 1993) point to the interaction of Vpx with the Gag proteins. In particular, Kappes et al. (1993) found that in cells transfected with a vpx gene from HIV-2, Vpx was spread throughout the cytoplasm whereas when these cells were also transfected with a vpx-deficient provirus of HIV-2, Vpx colocalized with the Gag proteins. To further define the role played by Gag proteins in packaging of Vpx we employed two vaccinia virus recombinants that encode the SIV ..... structural proteins known to be sufficient for the assembly of virus-like particles. In agreement with the recent report of Gonzales et at. (1993) we have found that expression of the myristylated p16 gaq (MA) alone results in the formation of virus-like particles. However, these particles failed to incorporate Vpx, suggesting that p16 gag (MA) on its own does not signal Vpx packaging although further studies are needed to exclude the possibility that p16 gag participates in packaging when synthesized as part of the Gag precursor. As have a number of other groups working on HIV and SIV (Delchambre et al., 1989; Gheysen et al., 1989; Haffar et al., 1990; Karacostas et al., 1989; Shioda & Shibuta, 1990; Vzorov et al., 1991) we demonstrated that the Gag precursor assembles into virus-like particles which are released into the culture medium. Vpx was packaged into such particles when produced in cells co-expressing the Gag precursor and Vpx. Therefore, considering that p16 gag (MA), the amino-terminal portion of the Gag polyprotein, does not incorporate Vpx into virus-like particles, the polypeptide sequences along the remaining portion of the Gag precursor [particularly p28 ga° (CA), p8 gag (NC) and p6 gag] may contain the essential signals for Vpx packaging. In this respect it is noteworthy that recent work with HIV-1 suggests that Vpr, a protein homologous to Vpx, is packaged into viral particles through its interaction with the carboxy-terminal portion of the Gag precursor (Paxton et al., 1994; Lu et at., 1994) .
A rough scheme for the incorporation of Vpx into viral particles and its positioning at the periphery of viral cores can now be proposed. After its synthesis in the cytoplasm, Vpx would bind to a region of the Gag polyprotein. The stoichiometry between the Gag proteins and Vpx within virions suggests that each Gag polyprotein should bind on average one Vpx protein.
Together, Gag and Vpx would migrate to the inner surface of the cytoplasmic cell membrane where they would become attached via the myristic acid moiety at the N-terminus of the Gag precursor. Budding and assembly of the core structure, brought about by cleavage of the Gag precursor, would reposition Vpx and lock it into the space separating the matrix p16 gag (MA) and the core p28 gag (CA) protein structures. A more precise definition of the polypeptide sequences required for the packaging of Vpx could be obtained by identifying mutations in the gag gene that do not alter the ability of the Gag polyprotein to assemble into particles but interfere with the packaging of Vpx. Furthermore, the effect of mutations in the vpx gene on the packaging of Vpx should also be investigated. Such studies may ultimately help in understanding the role that Vpx may play as a structural protein during the viral life cycle as well as the strict requirement for Vpx in infection of primary lymphoid cell cultures and in SIV pathogenicity.
